Cartesian Therapeutics (RNAC) Return on Sales [ROS] (2015 - 2026)
Cartesian Therapeutics (RNAC) posted Return on Sales [ROS] of -10518.55% for Q2 2026, down 3199.42 percentage points from -7319.13% a year earlier but up 23454.53 percentage points from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Return on Sales [ROS] (2015 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics' Return on Sales [ROS] came in at -5127.10%, down 5014.29 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -4784.74 percentage points (FY2020 to FY2025).
- In prior years, Cartesian Therapeutics' Return on Sales [ROS] was -112.81% in FY2024 (+219.51 pp), -332.32% in FY2023 (-345.44 pp), 13.12% in FY2022 (+18.53 pp) and -5.40% in FY2021 (+336.95 pp).
- Quarterly Return on Sales [ROS] has run from a low of -33973.08% in Q1 2026 to a high of 41.13% in Q2 2024 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last six quarters, with an average year-over-year change of -7078.73 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2024, with a gain of 396.21 percentage points; the weakest was Q1 2026, with a drop of 31983.17 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -33973.08% (Q1 2026), -8304.01% (Q4 2025) and -4660.62% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Cartesian Therapeutics | 221.08 Mn | 221.08 Mn | - | -10,518.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,518.55% |
| Mar 31, 2026 | -33,973.08% |
| Dec 31, 2025 | -8,304.01% |
| Sep 30, 2025 | -4,660.62% |
| Jun 30, 2025 | -7,319.13% |
| Mar 31, 2025 | -1,989.91% |
| Dec 31, 2024 | -112.81% |
| Sep 30, 2024 | -4,541.34% |
| Jun 30, 2024 | 41.13% |
| Mar 31, 2024 | -228.56% |
| Dec 31, 2023 | -439.54% |
| Sep 30, 2023 | -199.44% |
| Jun 30, 2023 | -355.08% |
| Mar 31, 2023 | -309.55% |
| Dec 31, 2022 | -50.59% |
| Sep 30, 2022 | -7.72% |
| Jun 30, 2022 | 35.29% |
| Mar 31, 2022 | 31.69% |
| Dec 31, 2021 | 13.62% |
| Sep 30, 2021 | -8.06% |
API Access
Cartesian Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();